908 Devices Acquires RedWave Technology, Expanding its Forensics Product Offering
Retrieved on:
火曜日, 4月 30, 2024
In addition, RedWave bolsters 908 Devices’ desktop portfolio with a line of accessories for pharma Process Analytical Technology (PAT) and industrial QC applications.
Key Points:
- In addition, RedWave bolsters 908 Devices’ desktop portfolio with a line of accessories for pharma Process Analytical Technology (PAT) and industrial QC applications.
- “We’re thrilled to welcome the RedWave team to 908 Devices.
- RedWave is a strong fit and enables us to accelerate our strategic objectives.”
“RedWave Technology and 908 Devices share an extraordinary passion for innovation and customer care,” said Jon Frattaroli, CEO of RedWave Technology, now VP, Strategy at 908 Devices. - RedWave is expected to contribute $11 million to 908 Devices’ 2024 reported revenue, representing eight months of ownership.